Strumento inattivo

Resoconti Regulus Therapeutics Inc Nasdaq

Azioni

US75915K1016

Resoconti

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Transcript : Regulus Therapeutics Inc. - Special Call	24/06
Transcript : Regulus Therapeutics Inc. - Special Call	12/03
Transcript : Regulus Therapeutics Inc. Presents at The 6th Annual Evercore ISI HealthCONx Conference, Nov-29-2023 10:25 AM	29/11
Transcript : Regulus Therapeutics Inc. - Special Call	20/09/23
Transcript : Regulus Therapeutics Inc. - Special Call	06/09/23
Transcript : Regulus Therapeutics Inc., Q3 2022 Earnings Call, Nov 10, 2022	10/11/22
Transcript : Regulus Therapeutics Inc., Q2 2022 Earnings Call, Aug 11, 2022	11/08/22
Transcript : Regulus Therapeutics Inc., Q1 2022 Earnings Call, May 12, 2022	12/05/22
Transcript : Regulus Therapeutics Inc., Q4 2021 Earnings Call, Mar 10, 2022	10/03/22
Transcript : Regulus Therapeutics Inc., Q3 2021 Earnings Call, Nov 10, 2021	10/11/21
Transcript : Regulus Therapeutics Inc. - Special Call	12/10/21
Transcript : Regulus Therapeutics Inc., Q2 2021 Earnings Call, Aug 10, 2021	10/08/21
Transcript : Regulus Therapeutics Inc. Presents at Oppenheimer Rare & Orphan Disease Summit, May-21-2021 11:35 AM	21/05/21
Transcript : Regulus Therapeutics Inc., Q1 2021 Earnings Call, May 13, 2021	13/05/21
Transcript : Regulus Therapeutics Inc. - Special Call	03/05/21
Transcript : Regulus Therapeutics Inc. - Special Call	06/11/18
Transcript : Regulus Therapeutics Inc., Q1 2018 Earnings Call, May 10, 2018	10/05/18
Transcript : Regulus Therapeutics Inc., Q4 2017 Earnings Call, Mar 07, 2018	07/03/18
Transcript : Regulus Therapeutics Inc., Q3 2017 Earnings Call, Nov 07, 2017	07/11/17
Transcript : Regulus Therapeutics Inc., Q2 2017 Earnings Call, Aug 01, 2017	01/08/17

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Resoconti Regulus Therapeutics Inc Nasdaq

Azioni

US75915K1016

Resoconti

Filtri